Vertex Pharmaceuticals Market Sentiment

Vertex Pharmaceuticals Inc

VRTXNASDAQ

Trade with Public

$515.50

0.870.17%

마지막 업데이트: Sep 16, 8:46 AM

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

Vertex Pharmaceuticals Market Sentiment

Market sentiment signals for Vertex Pharmaceuticals (VRTX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 2.1% short float

Options Flow▲ 0.00 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

33 analysts

Options Flow (P/C)

0.00

More calls — Bullish

9 calls · 0 puts

Avg Consensus PT

$543

+5.3%

Highest Price Target

$665

+29.0%

Morgan Stanley

Lowest Price Target

$350

-32.1%

Baird

Short Interest

2.1%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 11, 2026	JP Morgan	Jessica Fye—	+8.6%	$515 → $560	Reinstates	Overweight
Sep 2, 2026	Morgan Stanley	Terence Flynn—	+29.0%	$665	Reinstates	Overweight
Aug 5, 2026	Truist Securities	Danielle Brill—	+9.6%	$560 → $565	Maintained	Buy
Aug 5, 2026	Barclays	Eliana Merle—	+19.7%	$615 → $617	Maintained	Overweight
Aug 4, 2026	TD Cowen	Phil Nadeau—	+6.7%	$525 → $550	Maintained	Buy
Aug 4, 2026	Cantor Fitzgerald	Carter Gould—	+15.4%	$590 → $595	Maintained	Overweight
Aug 4, 2026	Canaccord Genuity	Whitney Ijem—	-14.3%	$436 → $442	Maintained	Hold
Jul 13, 2026	UBS	Michael Yee—	+13.5%	$545 → $585	Maintained	Buy
Jul 13, 2026	Truist Securities	Danielle Brill—	+8.6%	$542 → $560	Maintained	Buy
Jul 7, 2026	RBC Capital	Brian Abrahams—	+10.6%	$543 → $570	Maintained	Outperform
Jul 7, 2026	Baird	Brian Skorney—	-32.1%	$330 → $350	Maintained	Underperform
May 6, 2026	Barclays	Eliana Merle—	+19.3%	$607 → $615	Maintained	Overweight
May 5, 2026	Canaccord Genuity	Whitney Ijem—	-15.4%	$437 → $436	Maintained	Hold
May 5, 2026	Morgan Stanley	Terence Flynn—	+19.5%	$612 → $616	Maintained	Overweight
May 5, 2026	Bernstein	William Pickering—	+11.0%	$577 → $572	Maintained	Outperform
May 5, 2026	RBC Capital	Brian Abrahams—	+5.3%	$541 → $543	Maintained	Outperform
Apr 30, 2026	Canaccord Genuity	Whitney Ijem—	-15.2%	$441 → $437	Maintained	Hold
Apr 10, 2026	Morgan Stanley	Terence Flynn—	+18.7%	$596 → $612	Maintained	Overweight
Mar 18, 2026	Maxim Group	Naz Rahman—	+11.5%	$575	Upgrade	Hold→Buy
Mar 11, 2026	Truist Securities	Joon Lee—	+1.8%	$490 → $525	Maintained	Buy
Mar 10, 2026	Morgan Stanley	Terence Flynn—	+15.6%	$570 → $596	Maintained	Overweight
Mar 10, 2026	B of A Securities	Ying Huang—	+16.0%	$571 → $598	Maintained	Buy
Mar 10, 2026	Citigroup	Geoff Meacham—	+13.5%	$575 → $585	Maintained	Buy
Mar 10, 2026	Oppenheimer	Jay Olson—	+16.4%	$540 → $600	Maintained	Outperform
Mar 10, 2026	Jefferies	Akash Tewari—	+12.5%	$580	Initiate	Buy